Introduction
Apoptosis is an active cellular suicide program through which cells perish without inducing an in¯ammatory response. It is now evident that apoptosis is actively suppressed through cellular survival pathways. PI3K is an important regulator of cell survival, and interference with its activity is sucient to reveal apoptosis in some instances. Other cellular signaling pathways including those that impinge upon MAPK/ERK and NFkB have also been implicated in cell survival. Like many of the eects of cAMP, its eects on apoptosis are highly cell-type dependent. Cyclic AMP (cAMP) stimulates apoptosis in lymphoid cell lines and thymocytes (Daniel et al., 1973; Walker et al., 1983; Myklebust et al., 1999; Gu et al., 2000) . In contrast, cAMP protects neutrophils (Niwa et al., 1999) and endothelial cells (Polte and Schroder, 1998) from TNFastimulated apoptosis and delays apoptosis induced by in vitro storage, cycloheximide treatment and exposure to anti-Fas antibodies (Parvathenani et al., 1998) . Cyclic AMP protects neuronal cells from apoptosis induced by trophic factor withdrawal (Xia et al., 1995) and cytokine treatment (Nobes and Tolkovsky, 1995) , rescues lymphocytes (Wilson et al., 1996) and hepatocytes (Fladmark et al., 1997) from Fasmediated apoptosis, attenuates cycloheximide-stimulated cell death in MCF-7 cells (Geier et al., 1995) , and inhibits bile acid-stimulated apoptosis in hepatocytes (Webster and Anwer, 1998) . Moreover, hormones (Kawakami et al., 1996) and bioactive peptides (Tanaka et al., 1994) that elevate cAMP are important survival factors.
Despite its broad role in ameliorating cell death, surprisingly little is known regarding the molecular mechanisms through which cAMP promotes cell survival. The doses of cAMP elevating agents used to stimulate apoptosis in some cells mediate survival in others. The goal of our studies was to identify the molecular targets of cAMP-mediated survival in thyroid cells where cAMP is a critical mediator of hormone action and an oncogene (Maenhaut et al., 1991; Wynford-Thomas, 1997) . Unlike many cells, thyroid cells are strikingly resistant to apoptosis (Dremier et al., 1994; Gire et al., 2000) . Fas ligation or addition of TRAIL, robust stimulators of apoptosis, required the concerted action of cycloheximide to stimulate apoptosis in human thyroid cells (Arscott et al., 1997; Bretz et al., 1999) . Only when coupled with deprivation of attachment did hormone withdrawal stimulate apoptosis in FRTL-5 cells (Li et al., 1999) . However, cytokines such as g-interferon or TNFa stimulate apoptosis in thyroid cells (Bretz et al., 1999; Saavedra, in preparation) . As these agents can act via NO, we tested whether NO donors such as SNP induced cell death in rat thyroid cells. We discovered that rat thyroid cells perish via apoptosis following treatment with SNP, and that cAMP elevating agents aord substantial protection from cell death. Unexpectedly, our studies revealed that basal PKA activity, as well as regulated Rap1 activity, play critical roles in the regulation of thyroid cell viability.
Results

Role of cAMP in cell survival
WRT cells survive for extended times in the absence of TSH, growth factors and serum without morphological evidence of cell death. To con®rm that these cells were capable of undergoing apoptosis, cells were incubated in the absence of hormone, serum and growth factors (basal medium) for 24 h prior to treatment with SNP. Apoptosis was evaluated by morphologic criteria and con®rmed by DNA fragmentation. Cells in basal medium exhibited a normal morphology ( Figure 1A , panels a, e). In contrast, SNP-treated cells exhibited striking morphological changes including increased rounding and refractility, membrane blebbing, and nuclear condensation (panels b, f). To con®rm that SNP-induced cell death was apoptotic, DNA fragmentation was analysed. FACS analysis revealed a characteristic shoulder representing fragmented DNA in SNP-treated cells ( Figure 1B ). The eects of SNP on DNA fragmentation were dose-dependent ( Figure 1C ). Cytokine-induced NO production is associated with increased cGMP formation in human thyroid cells (Motohashi et al., 1996) . Therefore, to determine whether cGMP might contribute to SNP-induced apoptosis, the eects of 8BrcGMP on hypodiploid DNA content were investigated. Whether used alone, or in combination with SNP, 8BrcGMP did not increase hypodiploid DNA content ( Figure 1C ). To con®rm that hypodiploid DNA content was an accurate measure of DNA fragmentation in these cells, DNA was isolated from control and SNP-treated cells and analysed by agarose gel electrophoresis. SNP stimulated DNA laddering, a hallmark of apoptosis ( Figure 2A ).
Cyclic AMP elicits pleiotropic eects on cell survival. Therefore experiments were conducted to ascertain if cAMP could rescue thyroid cells from SNP-induced apoptosis. Pretreatment with cAMP elevating agents ameliorated the morphological changes induced by SNP ( Figure 1A , panels c, d, g, h) and marked reduced the proportion of cells with hypodiploid DNA (Figure 1B ). Multiple cAMP elevating agents and the phosphodiesterase inhibitor IBMX (1 mM) exhibited similar death sparing eects ( Figure 2B ). Protection aorded by these agents was incomplete. On the average, a 50% reduction in the proportion of apoptotic cells was observed. This agrees well with the death sparing eects of cAMP (Mebmer et al., 1995; Polte and Schroder, 1998; Webster and Anwer, 1998) , IBMX (Niwa et al., 1999) and RO 20-1724 (Ottonello et al., 1998 reported in other cells. Most importantly, TSH rescued cells from apoptosis (Figures 2A,B) suggesting that this hormone may be an important modulator of cell survival in vivo.
The inhibitory eects of cAMP on apoptosis were not a consequence of cell replacement because cAMP is a poor mitogen in these cells in the absence of insulin (Cass and Meinkoth, 1998; Medina and Santisteban, 2000) . Moreover, when used at concentrations that elicited maximal protection from apoptosis, IBMX (1 mM) not only failed to stimulate DNA synthesis, but impaired the mitogenic activity of TSH ( Figure 2C ). At lower concentrations where IBMX (0.1 mM) stimulated DNA synthesis, it failed to promote survival (data not shown). These ®ndings indicate that discrete cAMPactivated signaling cascades regulate mitogenesis and survival.
p70S6k contributes to cAMP-mediated survival
Cyclic AMP activates multiple signaling pathways including PKA-dependent signals to PI3K (Tsygankova et al., 2001 ) and p70S6k (Cass et al., 1999) . Given the important role of PI3K in cell survival, its contribution to thyroid cell viability was assessed. Treatment with wortmannin at a concentration sucient to repress cAMP-stimulated DNA synthesis (Cass et al., 1999) had no eect on basal levels of apoptosis, nor did it increase the frequency of apoptosis in SNPtreated cells ( Figure 3A) . Further, pretreatment with PI3K inhibitors did not impair the ability of forskolin, IBMX ( Figure 3A ) or TSH ( Figure 3B ) to rescue cells from SNP-induced death. Treatment with rapamycin at concentrations up to 10-fold higher than those required to block cellular p70S6k activity (Cass and Meinkoth, 1998) failed to stimulate apoptosis under hormone-free conditions ( Figure 4A ). Rapamycin did not signi®-cantly enhance SNP-induced apoptosis, although the proportion of apoptotic cells was consistently increased in SNP-treated cells exposed to rapamycin. Compared to treatment with forskolin or IBMX alone, however, cells pretreated with rapamycin exhibited a statistically signi®cant increase in hypodiploid DNA content ( Figure 4B ). Similar eects were seen with TSH ( Figure  4C ). Therefore, the ability of cAMP to protect thyroid cells from SNP-induced apoptosis appears to be independent of PI3K activity, but relies in part on cAMP-stimulated p70S6k activity.
PKA is required for thyroid cell survival
PKA is required for cAMP eects on p70S6k (Cass et al., 1999) and PI3K (Tsygankova et al., 2001) activity. Unexpectedly, inclusion of the cell permeable PKA inhibitor, H89, in basal medium stimulated morphologic features of apoptosis and decreased cell number ( Figure 5A ). H89-treated cells exhibited DNA fragmentation that was dose-dependent ( Figure 5B ,C). When used at 25 mm, H89 signi®cantly increased DNA fragmentation, implicating PKA as an important contributor to thyroid cell survival in the absence of TSH. Although H89 treatment alone at concentrations less than 10 mm did not impact survival under hormone-free conditions, it elicited marked synergistic eects on SNP-stimulated apoptosis ( Figure 6 ).
Although reported to be selective for PKA at concentrations up to 30 mm (Chijiwa et al., 1990) , a recent report indicates that H89 impairs the activity of several protein kinases including p70S6k (Davies et al., 2000) . To test that other mechanisms of inhibiting PKA also trigger apoptosis, an expression vector encoding a mutant type I regulatory subunit that binds catalytic subunit in the presence and absence of cAMP (Bubis et al., 1988) . Injection of RI209K into cells in basal medium resulted in substantial cell loss (Table 1 ) and the appearance of injected cells with an apoptotic morphology (Figure 7) . The eects of RI209K were both time-and dosedependent. Importantly, similar eects were not observed in control injections using IgG alone, empty vector, or a variety of other expression constructs. While these ®ndings support the notion that PKA is an important regulator of thyroid cell survival, they precluded an analysis of the requirement for PKA in cAMP-promoted survival.
Effects of Rap1 on thyroid cell survival
Both cAMP and PKA contribute to Rap1 activity in WRT cells (Tsygankova et al., 2001) . Therefore, we examined whether modulations in Rap1 activity aected cell survival. Given the low transfection eciency of thyroid cells, WRT cells stably expressing activated (Rap1A63E), cellular (Rap1A) and dominant negative (Rap1A17N) forms of Rap1A were used for these studies (described in Tsygankova et al., 2001) . Basal levels of apoptosis were similar in Rap1A-transfected and parental cells (data not shown). Strikingly, SNP-induced hypodiploid DNA content was markedly attenuated in Rap1A17N-expressing cells compared to parental cells ( Figure 8A ). Consistently, DNA laddering was not detected in these cells following 24 h of SNP treatment, a condition where laddering was observed in parental ( Figure 2A ) and Rap1A63E ( Figure 8B ) cells. Furthermore, Rap1A17N cells exhibited a normal cell morphology despite exposure to SNP for up to 23 h ( Figure 8D ).
Unlike cells expressing dominant negative Rap1A, Rap1A63E cells underwent more rapid and extensive morphological changes ( Figure 8D ) and DNA laddering ( Figure 8C ) in response to SNP than did parental cells. These eects were restricted to cells expressing the activated Rap1A mutant and were not observed in Rap1A-overexpressing cells (data not shown). Although ectopic Rap1A expression in all cases was considerably lower than endogenous Rap1A expression (Tsygankova et al., 2001) , cell lines exhibiting higher Rap1A63E expression exhibited more robust apoptotic eects in response to SNP ( Figure 8A ). The accelerated progress of apoptosis in Rap1A63E cells, together with the attenuated response in Rap1A17N cells implicates a role for Rap1 in the regulation of SNP-stimulated Cyclic AMP has been reported to stimulate Rap1-dependent MAPK activity in cells expressing B-Raf (Vossler et al., 1997) . Although WRT cells express the 67 and 95 kDa isoforms of B-Raf, the eects of cAMP on MAPK activation were not altered by ectopic expression of cellular, activated or dominant negative Rap1A (Figure 9 ). Cyclic AMP can rescue neuronal cells from death induced by trophic factor withdrawal through eects on MAPK (Dugan et al., 1999) . While cAMP stimulates PKA-dependent eects on MAPK activity in WRT cells ( Figure 9C ), interference with MEK1 activity did not impair rescue from SNPinduced apoptosis by cAMP elevating agents (data not shown). Based on this, it seems unlikely that the requirement for PKA in thyroid cell survival is secondary to eects on MAPK, or that Rap1 impairs survival through eects on MAPK activity.
Discussion
Although widely described, the survival pathways activated by cAMP are poorly understood. In this report, the relative contributions of discrete eectors of cAMP were assessed for their roles in thyroid cell survival. We demonstrate for the ®rst time a signi®cant and essential role for PKA in maintaining thyroid cell viability. Our data also revealed that alterations in Rap1A activity impact the delicate balance between survival and apoptosis in thyroid cells.
Thyroid cells are markedly resistant to apoptosis even following prolonged incubation in the absence of TSH. Unlike many cells, exposure of human (Gire et al., 2000) or rat (Cheng and Meinkoth, 2001 ) thyroid cells to inhibitors of PI3K or MEK failed to stimulate cell death, even under conditions of prolonged growth factor withdrawal. In contrast, treatment with cytokines (Saavedra, in preparation) or NO donors such as SNP stimulated apoptotic cell death. Similar to reports in other cell types (Mebmer et al., 1995; Jun et al., 1998) , cAMP elevating agents elicited potent antiapoptotic eects in thyroid cells exposed to SNP. While cAMP elicits many eects through PKA, cAMP activates Rap1 through a PKA-independent mechanism in thyroid cells (Dremier et al., 2000; Tsygankova et al., 2001) . Similar PKA-independent eects of cAMP on Rap1 activity have been reported in many (Altschuler et al., 1995; Kawasaki et al., 1998; DeRooij et al., 1998; Lintig et al., 2000; Busca et al., 2000) , but not all (Vossler et al., 1997; Schmitt and Stork, 2001; Zanassi et al., 2001) cells. Based on this, the role of PKA-dependent and -independent pathways in the regulation of cell survival were assessed.
Cyclic AMP promotes survival through PKAdependent signaling pathways in many cells. In HL-60 cells (Jun et al., 1998) , rat hepatocytes (Webster and Anwer, 1998), and human neutrophils (Ottonello et al., 1998) , protection from apoptosis aorded by cAMP was impaired by PKA inhibitors. Strikingly, both WRT and FRTL-5 cells (data not shown) died at a signi®cant rate following treatment with H89, and H89 markedly enhanced apoptosis stimulated by SNP. Like many cell permeable inhibitors, H89 eects are not entirely speci®c for PKA and this inhibitor also impairs p70S6k activity (Davies et al., 2000) . Rapamycin, an inhibitor that prevents activation of p70S6k, did not increase basal levels of apoptosis in WRT cells, making it unlikely that H89 elicits its death-promoting eects through p70S6k inhibition. In addition, microinjection of a mutant PKA regulatory subunit that sequesters catalytic subunit also stimulated apoptosis. Together, these data support an essential role for PKA in the maintenance of thyroid cell survival even in starved cells where cAMP levels are low. Phosphorylation of key substrates by PKA may still occur under these conditions. In neurons, synaptic substrates of PKA appear to be phosphorylated in a cAMP-independent fashion (Banke et al., 2000) . Moreover, similar to our observations in thyroid cells, interference with PKA activity in the absence of cAMP elevation enhanced Fas-mediated apoptosis in primary rat hepatocytes (Fladmark et al., 1997) and augmented radiationinduced apoptosis (Findik et al., 1995) in human cells.
Rapamycin partially impaired cAMP-stimulated rescue, suggesting that PKA-dependent signals to p70S6k contribute to thyroid cell survival induced by cAMP. The modest eects of rapamycin on rescue also indicate that there are likely to be additional important mediators of thyroid cell survival. PKA-dependent mediators may include members of the CREB/ATF-1 family as these proteins are important survival factors Figure 7 Microinjection of an RI209K expression vector stimulates apoptosis. Cells incubated in basal medium for 24 h were injected with pcDNA3 encoding RI209K, empty vector, or IgG alone. After 24 h, the cells were ®xed and stained for coinjected IgG and nuclear morphology for many cells including neurons (Riccio et al., 1999; Walton et al., 1999) and other endocrine cells (Somers et al., 1999) . Signals activated by PKA and P13K converge in the regulation of CREB (Du and Montminy, 1998), Bad (Harada et al., 1999; Tan et al., 2000) and GSK-3b (Li et al., 2000) , a ®nding that may indicate that PKA regulates thyroid cell survival through mechanisms similar to those used by P13K in other cells. Our ®ndings suggest a previously unidenti®ed role for Rap1 in the regulation of thyroid cell survival, at least in response to SNP, but perhaps also in response to cytokines. In support of this notion, cAMPregulated guanine nucleotide exchange factors for Rap1 are highly expressed in thyroid tissue (Kawasaki et al., 1998) , and cAMP activates Rap1 in canine (Dremier et al., 2000) and rat (Tsygankova et al., 2001) thyroid cells. Importantly, SNP-stimulated apoptosis was enhanced in thyroid cells stably expressing activated Rap1A and impaired in cells expressing dominant negative Rap1A. Two signals activated upon SNP treatment have been linked either directly or indirectly to the regulation of Rap1 activity. Treatment with 8BrcGMP activated Rap1 in HL-60 cells (Lintig et al., 2000) , and NO stimulated Ras activity through eects on a domain conserved in Rap1 (Lander et al., 1997) . Whether apoptosis in thyroid cells is a direct consequence of SNP eects on Rap1 activity together with other signals, or secondary to chronic alterations in cellular Rap1 activity is not yet clear. The ®nding that SNP-stimulated cell death is attenuated in Rap1A17N cells where activation of cellular Rap1 is also impaired (Tsygankova et al., 2001) supports the idea that Rap1 activity is required for SNP-stimulated apoptosis.
At ®rst glance, cAMP eects on Rap1 activity and apoptosis would seem incompatible with the role of cAMP as a survival factor. This is not necessarily the case in that cAMP activates both Rap1 and PKA, and these proteins elicit opposing eects on cell survival. We recently reported that PKA inhibitors prolong Rap1 activity in WRT cells (Tsygankova et al., 2001) . These results indicate that PKA is a negative regulator of Rap1 activity, an eect that may be particularly important given the stimulatory eects of activated Rap1 on apoptosis in these cells. Although activated in a PKAindependent manner, Rap1 may be another target of PKA-mediated survival signals. It seems unlikely that apoptosis induced by PKA inhibitors is elicited solely through eects on Rap1 given the relatively modest eects of activated Rap1A on apoptosis. Additionally, cells expressing dominant negative Rap1A remained sensitive to H89-induced apoptosis.
Although both are cAMP-mediated, the pathways regulating proliferation and survival are distinct. TSH and cAMP elevating agents promote survival in the absence of insulin, conditions where they are ineective mitogens (Brandi et al., 1987; Cass and Meinkoth, 1998) . Moreover, IBMX at high concentration (1 mM) is a potent survival factor, but fails to stimulate DNA synthesis and represses the mitogenic activity of TSH in WRT cells as it does in FRTL-5 cells (Villone et al., 1997) . The dierential contributions of PI3K and p70S6k to cAMP-induced survival further highlight the discrete nature of signals regulating proliferation and survival. Both p70S6k (Cass and Meinkoth, 1998) and PI3K (Cass et al., 1999) contribute to cAMPstimulated proliferation. Nonetheless, only p70S6k contributes to cell survival aorded by cAMP. In many cells, p70S6k has been dissociated from the survival promoting eects of PI3K and Akt (Yao and Cooper, 1996; Khwaja et al., 1997) . It is interesting to speculate that the role of p70S6k in modulating survival in thyroid cells may be related to the unique aspects of cAMP regulation of p70S6k activity (reviewed in Richards, 2001) . Cyclic AMP activates p70S6k in cells where it stimulates cell cycle progression, but not in cells where it impairs proliferation (Cass and Meinkoth, 1998) .
In summary, our ®ndings highlight the increasing complexity of signaling initiated by cAMP. In thyroid cells, cAMP generates a potent survival signal. These ®ndings suggest that the oncogenic activity of cAMP in these cells may derive from its stimulatory eects on cell proliferation as well as on cell survival. Cyclic AMP modulates the activity of multiple downstream eectors including PKA, p70S6k, PI3K, MAPK and Rap1. PKA may be required not only to stimulate pro-survival signals, but to impair pro-apoptotic signals initiated by Rap1. Acting in concert, these molecules ensure that cells are poised to respond to signals with survival, proliferation and dierentiation. . Cells were starved in basal medium for 48 h and subsequently stimulated with TSH (1 mU/ml) for the times shown (min). Whole cell extracts (20 mg) were subjected to Western blotting with a phospho-speci®c MAPK antibody. (C) Cells were starved and treated as described in (B) except that replicate plates were pretreated with H89 (10 mM) for 30 min prior to treatment with TSH for the indicated times (min)
Materials and methods
Reagents
Rapamycin, H89 and wortmannin were purchased from Calbiochem (La Jolla, CA, USA). SNP, insulin, transferrin, crude bovine TSH, forskolin, 8BrcAMP and IBMX were from Sigma (St. Louis, MO, USA).
Cell culture
WRT cells were maintained in Coon's modi®ed Ham's F12 medium supplemented with crude bovine TSH (1 mU/ml), insulin (10 mg/ml), transferrin (5 mg/ml), and 5% calf serum (3H medium) as described previously (Kupperman et al., 1996) . Cells expressing mutant forms of Rap1A (Maly et al., 1994) were generated by lipofectin-mediated transfection and maintained in 3H containing 150 mg/ml G418 (described in Tsygankova et al., 2001) . Four independent cell lines expressing Rap1A63E and two independent lines expressing Rap1A17N were analysed with similar results.
FACS analysis for hypodiploid DNA content
Cells were plated overnight in 2H medium (medium lacking TSH) and starved in basal medium (Coon's modi®ed F-12 medium containing 0.2% fatty acid-free BSA) for 24 h. SNP and H89 were added for 6 ± 24 h. In rescue experiments, cAMP elevating agents were added 45 min prior to SNP. Where inhibitors were used, they were added 30 ± 60 min prior to cAMP elevating agents. Following treatment, medium and oating cells were collected, adherent cells released by trypsinization and added to the recovered supernatant. Cells were collected by centrifugation, ®xed in 70% EtOH in PBS (48C) for 30 min, stained with propidium iodide (0.1 mg/ml) in 0.1% Triton X-100, 0.1 mM EDTA, 100 U/ml RNAse A in PBS for 30 min and subjected to FACS analysis.
Morphological analysis of apoptosis
Cells were plated on coverslips in 2H overnight, incubated in basal medium for 24 h and treated as for FACS analysis described above. Cells were ®xed in situ in 3.7% formaldehyde/ PBS, permeabilized with 0.1% Tween-20 for 2 min, stained with Hoechst 33258 (1 mg/ml) for 5 min and analysed by phase contrast and¯uorescence microscopy. Duplicate slips for each treatment were scored blinded by two examiners. At least 3 ± 5 random ®elds (150 ± 300 cells) were examined per treatment.
DNA laddering
DNA was isolated using the Easy-DNA kit from Invitrogen (San Diego, CA, USA) and analysed by agarose (1.2%) gel electrophoresis as described previously (Cheng and Meinkoth, 2001 ).
DNA synthesis
DNA synthesis was assessed by bromodeoxyuridine (BrdU) incorporation as described in (Kupperman et al., 1993; Cass and Meinkoth, 1998) . Cells were arrested in insulin (0.5 mg/ ml)-supplemented basal medium for 48 h, and then stimulated with cAMP elevating agents in the presence of BrdU for 48 h. Following ®xation, the cells were stained for BrdU incorporation, and the percentage cells with replicated DNA scored. Over 200 cells on duplicate coverslips were scored blinded for each condition.
Microinjection
Cells plated on glass coverslips and grown to 80% con¯uence were transferred to basal medium for 24 h, and then injected into the nucleus with an expression vector encoding RI209K or control expression vectors. Plasmid DNA was co-injected with rabbit IgG (4 mg/ml) to identify injected cells. After various times, the cells were ®xed in 3.7% formaldehyde/PBS, stained with FITC-anti-rabbit IgG and Hoechst 33258 and analysed by¯uorescence microscopy.
Western blotting
Whole cell lysates were prepared and 20 ± 40 mg analysed as described previously (Tsygankova et al., 2001 ). The Raf-1 and B-Raf antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA) and the phospho-speci®c MAPK antibody from Promega (Madison, WI, USA).
Statistical analysis
Sample means and standard errors are reported for each experimental group. Statistical signi®cance and P-values were calculated using the two-sample t test for independent samples with unequal variances. All reported experiments were performed 3 ± 5 times with similar results.
